NCT01744444 - Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis | Biotech Hunter

Enrollment

10

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Pendular Nystagmus Patients With Multiple Sclerosis

Interventions

DRUG

Memantine

Patients will be randomly assigned to start on either memantine or gabapentin. For tolerance reasons, each treatment begins with a progressive increasing dose and stops with a progressive decreasing dose. The duration of the period of last dose (8 to 11 days) will be chosen according to the investigator's availability to organize post-tests.

DRUG

Gabapentin

Patients will be randomly assigned to start on either memantine or gabapentin. For tolerance reasons, each treatment begins with a progressive increasing dose and stops with a progressive decreasing dose. The duration of the period of last dose (8 to 11 days) will be chosen according to the investigator's availability to organize post-tests.

Trial Locations (1)

69677

Hôpital Neurologique Unité de Neuro-Ophtalmologie, Bron